Data is not available at this time.
3D Systems Corporation operates in the additive manufacturing industry, providing 3D printing solutions, materials, software, and services. The company serves diverse sectors, including healthcare, aerospace, automotive, and industrial markets, leveraging its proprietary technologies to enable rapid prototyping, production-grade manufacturing, and customized solutions. Its revenue model combines hardware sales, recurring material and software subscriptions, and professional services, positioning it as an end-to-end provider in the growing digital manufacturing ecosystem. 3D Systems holds a competitive edge through its advanced polymer and metal printing capabilities, complemented by a robust intellectual property portfolio. While facing competition from Stratasys, HP, and emerging players, the company maintains a strong presence in niche applications like dental and medical devices, where precision and customization are critical. Its focus on high-value industrial and healthcare applications differentiates it from consumer-oriented 3D printing firms, though macroeconomic pressures and technological shifts remain key challenges.
3D Systems reported revenue of $440.1 million for FY 2024, reflecting its mid-scale position in the additive manufacturing market. The company posted a net loss of $255.6 million, with diluted EPS of -$1.94, indicating ongoing profitability challenges. Operating cash flow was negative at $44.9 million, while capital expenditures totaled $16.1 million, suggesting constrained cash generation relative to reinvestment needs.
The company’s negative earnings and cash flow underscore inefficiencies in translating revenue into profitability. High R&D and operational costs in a competitive landscape have eroded margins, though its focus on industrial and healthcare applications may yield higher-margin opportunities over time. Capital efficiency remains under pressure, with cash burn outpacing operational adjustments.
3D Systems holds $171.3 million in cash and equivalents against $286.1 million in total debt, indicating a leveraged position with moderate liquidity. The absence of dividends aligns with its reinvestment priorities, but sustained losses could strain financial flexibility if not offset by improved cash flow or external financing.
Revenue trends are tied to adoption cycles in industrial and healthcare 3D printing, with growth potential offset by macroeconomic headwinds. The company does not pay dividends, prioritizing capital allocation toward innovation and market expansion. Long-term growth hinges on scaling high-margin applications and reducing operational costs.
Market valuation likely reflects skepticism about near-term profitability, given persistent losses and cash flow challenges. Investors may be pricing in turnaround potential or strategic shifts, but execution risks remain elevated in a capital-intensive industry.
3D Systems’ IP portfolio and vertical expertise in healthcare and aerospace provide differentiation, but execution is critical to monetizing these advantages. The outlook depends on balancing innovation with cost discipline, while navigating competitive and technological disruptions in additive manufacturing.
Company filings (10-K), financial statements
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |